Assisted fundraising

Log in  |  Sign up

  • Home
  • Guides
  • Assets
  • Investors
    • VC funds
    • Tailored lists
    • Favorites
  • Academy
  • Privacy policy
    • Terms of Use
    • Privacy Policy
  • Help center
  • Return to waveup.com

Fund profile

Previz Ventures

Previz Ventures

Herzliya, Israel

Not leading

About

Previz Ventures is a tech and life sciences-focused early-stage venture capital firm founded in 2011 and headquartered in Herzliya, Israel. The firm invests into innovative technology companies addressing critical challenges in medical devices and healthcare information and communications technology, with a clearly defined entry point at post proof-of-concept, initial-to-approaching-commercial stage companies targeting large, underserved markets with scalable solutions. Previz concentrates overwhelmingly on Israeli-based companies to leverage the density of deep-tech talent in the Israeli ecosystem and the unique market access of its management team. The firm is led by founder and Managing Director Eliav Azulay Oz and operates with a small three-person team consistent with its selective, concentrated portfolio strategy. Previz has made approximately 8 disclosed investments and has a strong exit track record relative to its size. ReWalk Robotics (formerly Argo Medical) — a powered exoskeleton enabling paralyzed individuals to walk, stand, sit, and climb stairs — completed a NASDAQ IPO in September 2014 at an approximately $136 million market cap. Orpheus Medical, an enterprise clinical-video imaging platform, was acquired by Intuitive Surgical in February 2020. Clear-Cut Medical (intra-operative compact MRI for margin assessment of cancerous tissue) was among the firm's later disclosed investments. Previz screens investment candidates not only for financial return potential but for the transformative social value they can create in healthcare — improving patient outcomes, quality of life, and access to care. This dual mandate shapes the firm's portfolio construction: each company must meet a high bar on both clinical significance and commercial scalability. The firm provides ongoing strategic guidance across the full investment life cycle, from initial product development through regulatory clearance and downstream financing.

Details

Average check

$500K-$1M
$1M-$3M
$3M-$10M

Round

Series A
Series B

Previous Investments

AI & Deep TechBiotechHardware. Robotics & IoTHealthtech & WellnessPharma

Geo focus

Israel

Highlights

May 2015

Last investment date

8

Investments

Healthtech & Wellness

Hardware. Robotics & IoT

Biotech

Pharma

Showing 0 lists

Filter by

Sort by

Contacts

Website

previzv.com

Social

Lists that include this fund